Drug combo breaks down cancer resistance to immunotherapy



Drug combo breaks down cancer resistance to immunotherapy

By combining a checkpoint inhibitor with a new immunocytokine, scientists at have made a breakthrough in fighting against immunotherapy-resistant cancers.

Materials provided by Ecole Polytechnique Fédérale de Lausanne. Original written by Nik Papageorgiou. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

1st June 2023

Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

Read more
31st May 2023

Plants remove cancer causing toxins from air

Read more
31st May 2023

How the flu virus hacks our cells

Read more